new_logo.png
North America Precision Medicine Market size to surpass $50bn by 2027, says Graphical Research
02 mai 2022 07h07 HE | Graphical Research
Pune, India, May 02, 2022 (GLOBE NEWSWIRE) -- As per a recent industry report put forward by Graphical Research, the North America precision medicine market is forecast to register its name in the...
Qualigen-Logo-Tag.png
Qualigen Therapeutics Appoints Shishir Sinha to Lead Diagnostics Division Following Promotion to Senior Vice President
29 avr. 2022 09h15 HE | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers...
Global Sleep Apnea Diagnostics Market
Global Sleep Apnea Diagnostics Market Report to 2030 - Opportunity Analysis and Industry Forecasts
28 avr. 2022 06h28 HE | Research and Markets
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "Sleep Apnea Diagnostics Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
Axim-Sapphire_Logo_-04 (1).png
AXIM Develops Quantitative Rapid Diagnostic Test for Lacritin; Now Boasts Four Dry Eye Disease Point-of-Care Biomarker Tests
27 avr. 2022 09h00 HE | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting Dry Eye...
PRPO logo.png
Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference
26 avr. 2022 10h00 HE | Precipio, Inc.
NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited to announce its participation and the presentation of HemeScreen,...
22157.jpg
Global Diagnostic Specialty Antibodies Market to 2029 - by Type, Clonality, Technique, Conjugate and Application
26 avr. 2022 06h13 HE | Research and Markets
Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Diagnostic Specialty Antibodies Market by Type, Clonality, Technique, Conjugate, and Application - Forecast to 2029" report has been added to...
TIP_link_300x300.jpg
Medical Imaging Informatics Market Size Worth $5.17Bn, Globally, by 2028 at 5% CAGR - Exclusive Report by The Insight Partners
25 avr. 2022 13h19 HE | The Insight Partners
New York, April 25, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Medical Imaging Informatics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Persbericht Biocartis Group NV: Biocartis kondigt presentatie van drie Idylla™ studies aan op 32ste Europees Congres voor Klinische Microbiologie & Infectieziekten (ECCMID)
25 avr. 2022 01h00 HE | Biocartis NV
PERSBERICHT: 25 april 2022, 07:00 CEST Biocartis kondigt presentatie van drie Idylla™ studies aan op 32ste Europees Congres voor Klinische Microbiologie & Infectieziekten (ECCMID) Mechelen,...
Press release Biocartis Group NV: Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
25 avr. 2022 01h00 HE | Biocartis NV
PRESS RELEASE: 25 April 2022, 07:00 CEST Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) Mechelen,...
Persbericht Biocartis Group NV: Biocartis kondigt presentatie aan van eerste prospectieve data uit valideringsstudie Merlin Test door partner SkylineDx op EADO 2022 conferentie
21 avr. 2022 01h01 HE | Biocartis NV
PERSBERICHT: 21 april 2022, 07:01 CEST Biocartis kondigt presentatie aan van eerste prospectieve data uit valideringsstudie Merlin Test door partner SkylineDx op EADO 2022 conferentie Mechelen,...